CBS 2019
CBSMD教育中心
中 文

充血性心力衰竭

Abstract

Recommended Article

Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial Heart failure with preserved ejection fraction: from mechanisms to therapies Dapagliflozin Effects on Biomarkers, Symptoms, and Functional Status in Patients With Heart Failure With Reduced Ejection Fraction: The DEFINE-HF Trial Vericiguat in Patients with Heart Failure and Reduced Ejection Fraction Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status - Results from the EMPEROR-Reduced Trial Cardiovascular Aging and Heart Failure: JACC Review Topic of the Week Vaccination Trends in Patients With Heart Failure - Insights From Get With The Guidelines–Heart Failure Left Ventricular Assist Devices: Synergistic Model Between Technology and Medicine

Clinical TrialVolume 71, Issue 23, June 2018

JOURNAL:J Am Coll Cardiol. Article Link

Progression of Device-Detected Subclinical Atrial Fibrillation and the Risk of Heart Failure

Wong JA, Conen D, Van Gelder IC et al. Keywords: atrial fibrillation; atrial fibrillation progression; health outcome; heart failure; predictors; subclinical atrial fibrillation

ABSTRACT